Neurological Biomarkers Market Report by Type, Application, End Use, and Region 2024-2032

The global neurological biomarkers market size reached US$ 8.9 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 24.0 Billion by 2032, exhibiting a growth rate (CAGR) of 11.65% during 2023-2032.

Neurological biomarkers are molecules present in the blood or cerebral spinal fluid (CSF) that support the diagnosis of brain disorders and monitor disease progression. The main sources of these biomarkers are genetic mutations, metabolite levels, brain imaging and changes in protein expression or post-translational modifications. As they detect biological responses to experimental drugs and aid in discovering new targets for therapeutic intervention, neurological biomarkers are widely used in clinical practice during drug development. Presently, researchers measure biomarker concentrations to provide non-invasive testing, earlier diagnosis and personalized treatments.

The rising occurrence of neurological disorders, such as stroke, motor neuron disease (MND), Alzheimer’s disease (AD), Parkinson’s disease (PD) and Huntington’s disease (HD), is escalating the need for faster drug development. This represents one of the primary factors impelling the market growth as biomarkers help measure the efficacy of new drugs and therapeutic strategies. The increasing adoption of minimally invasive procedures and personalized medicines are acting as another major growth-inducing factor.

Apart from this, as various neurological disorders share standard features, there is an increase in the demand for multiple biomarkers to differentiate specific diseases and their sub-types. Moreover, advancements in mass spectrometry and imaging procedures enable faster evaluation of large numbers of biochemical markers and structural changes in the brain. This, along with the introduction of digital biomarkers and the rising number of clinical trials, is anticipated to propel the growth of the market in the coming years.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global neurological biomarkers market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, application and end use.

Breakup by Type:

Genomic Biomarkers
Proteomic Biomarkers
Metabolomic Biomarkers
Imaging Biomarkers
Others

Breakup by Application:

Alzheimer's Disease
Parkinson's Disease
Multiple Sclerosis
Autism Spectrum Disorders
Others

Breakup by End Use:

Hospital Laboratories
Clinical Diagnostic Centers
Research Organizations
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Acumen Pharmaceuticals Inc., Athena Diagnostics (Quest Diagnostics), Banyan Biomarkers Inc., Bio-Rad Laboratories Inc., Immunarray Pvt. Ltd., Myriad Rbm Inc. (Myriad Genetics Inc.), Proteome Sciences Plc and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

How has the global neurological biomarkers market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global neurological biomarkers market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end use?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global neurological biomarkers market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Neurological Biomarkers Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Genomic Biomarkers
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Proteomic Biomarkers
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Metabolomic Biomarkers
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Imaging Biomarkers
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast

7 Market Breakup by Application

7.1 Alzheimer's Disease
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Parkinson's Disease
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Multiple Sclerosis
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Autism Spectrum Disorders
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast

8 Market Breakup by End Use

8.1 Hospital Laboratories
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Clinical Diagnostic Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Research Organizations
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast

9 Market Breakup by Region

9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Acumen Pharmaceuticals Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Athena Diagnostics (Quest Diagnostics)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Banyan Biomarkers Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Bio-Rad Laboratories Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Immunarray Pvt. Ltd.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Myriad Rbm Inc. (Myriad Genetics Inc.)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Proteome Sciences Plc
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Thermo Fisher Scientific Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis

List of Figures

Figure 1: Global: Neurological Biomarkers Market: Major Drivers and Challenges
Figure 2: Global: Neurological Biomarkers Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Neurological Biomarkers Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Neurological Biomarkers Market: Breakup by Type (in %), 2023
Figure 5: Global: Neurological Biomarkers Market: Breakup by Application (in %), 2023
Figure 6: Global: Neurological Biomarkers Market: Breakup by End Use (in %), 2023
Figure 7: Global: Neurological Biomarkers Market: Breakup by Region (in %), 2023
Figure 8: Global: Neurological Biomarkers (Genomic Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Neurological Biomarkers (Genomic Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Neurological Biomarkers (Proteomic Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Neurological Biomarkers (Proteomic Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Neurological Biomarkers (Metabolomic Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Neurological Biomarkers (Metabolomic Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Neurological Biomarkers (Imaging Biomarkers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Neurological Biomarkers (Imaging Biomarkers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Neurological Biomarkers (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Neurological Biomarkers (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Neurological Biomarkers (Alzheimer's Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Neurological Biomarkers (Alzheimer's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Neurological Biomarkers (Parkinson's Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Neurological Biomarkers (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Neurological Biomarkers (Multiple Sclerosis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Neurological Biomarkers (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Neurological Biomarkers (Autism Spectrum Disorders) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Neurological Biomarkers (Autism Spectrum Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Neurological Biomarkers (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Neurological Biomarkers (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Neurological Biomarkers (Hospital Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Neurological Biomarkers (Hospital Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Neurological Biomarkers (Clinical Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Neurological Biomarkers (Clinical Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Neurological Biomarkers (Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Neurological Biomarkers (Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Neurological Biomarkers (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Neurological Biomarkers (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: North America: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: North America: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: United States: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: United States: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Canada: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Canada: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Asia-Pacific: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Asia-Pacific: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: China: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: China: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Japan: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Japan: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: India: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: India: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: South Korea: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: South Korea: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Australia: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Australia: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Indonesia: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Indonesia: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Others: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Others: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Europe: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Europe: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Germany: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Germany: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: France: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: France: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: United Kingdom: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: United Kingdom: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Italy: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Italy: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Spain: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Spain: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Russia: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Russia: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Others: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Others: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Latin America: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Latin America: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Brazil: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Brazil: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Mexico: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Mexico: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Others: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Others: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Middle East and Africa: Neurological Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Middle East and Africa: Neurological Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Middle East and Africa: Neurological Biomarkers Market: Breakup by Country (in %), 2023
Figure 85: Global: Neurological Biomarkers Industry: SWOT Analysis
Figure 86: Global: Neurological Biomarkers Industry: Value Chain Analysis
Figure 87: Global: Neurological Biomarkers Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Neurological Biomarkers Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Neurological Biomarkers Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Neurological Biomarkers Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 4: Global: Neurological Biomarkers Market Forecast: Breakup by End Use (in Million US$), 2024-2032
Table 5: Global: Neurological Biomarkers Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Neurological Biomarkers Market: Competitive Structure
Table 7: Global: Neurological Biomarkers Market: Key Players

Companies Mentioned

Abbott Laboratories
Acumen Pharmaceuticals Inc.
Athena Diagnostics (Quest Diagnostics)
Banyan Biomarkers Inc.
Bio-Rad Laboratories Inc.
Immunarray Pvt. Ltd.
Myriad Rbm Inc. (Myriad Genetics Inc.)
Proteome Sciences Plc
Thermo Fisher Scientific Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	142
Published	August 2024
Forecast Period	2023 - 2032
Estimated Market Value ( USD ) in 2023	$ 8.9 Billion
Forecasted Market Value ( USD ) by 2032	$ 24 Billion
Compound Annual Growth Rate	11.7%
Regions Covered	Global
No. of Companies Mentioned	9

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3828EUR$3,899USD£3,194GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€4810EUR$4,899USD£4,013GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€5792EUR$5,899USD£4,833GBP

Key Market Segmentation:

Breakup by Type:

Breakup by Application:

Breakup by End Use:

Breakup by Region:

Competitive Landscape:

Key Questions Answered in This Report:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Neurological Biomarkers Market by Type, Application, End-user - Global Forecast 2025-2030

Neurological Biomarkers for Alzheimer`S and Parkinson`S Diseases - Global Strategic Business Report

Neurological Biomarkers Global Market Report 2024

Neurological Biomarkers Market Size, Share & Trends Analysis Report by Application (Alzheimer's, Parkinson's, Multiple Sclerosis, Autism), Type, End-use, Region, and Segment Forecasts, 2024-2030

Neurological Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2030